CompletedNAINTERVENTIONAL
To Evaluate the Efficacy and Safety of NMN as an Anti-ageing Supplement in Middle Aged and Older (40-65 Years) Adults
- Sponsor:
- Abinopharm, Inc
- Conditions:
- Aging
- Enrollment:
- 90
- Started:
- May 2021
NCT04823260
Human trials
Where longevity science meets human data: registered trials of aging interventions, pulled daily from ClinicalTrials.gov. Status, phase, sponsor, and enrollment for each.
NCT04823260
NCT03509259
NCT02065687
NCT04496856
NCT03747107
NCT04720014
NCT04515160
NCT03370471
NCT02942888
NCT05009641
NCT04932720
NCT04589793
NCT04459351
NCT03736135
NCT04962464
NCT03799952
NCT03154073
NCT02702635
NCT01030874
NCT04939155
NCT03677726
NCT04136847
NCT04901520
NCT04401930
Literature and preprints via Europe PMC. Trial data from ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine. We store metadata and abstracts and link to every source record. This is educational information, not medical advice.